480 related articles for article (PubMed ID: 19505285)
1. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
Subramaniam V; Lip GY
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
[TBL] [Abstract][Full Text] [Related]
2. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
Gradman AH; Alfayoumi F
Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
[TBL] [Abstract][Full Text] [Related]
3. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
4. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy and heart failure in women.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
Agabiti-Rosei E; Muiesan ML; Salvetti M
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drugs and the heart.
Diamond JA; Phillips RA
Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
[TBL] [Abstract][Full Text] [Related]
10. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
11. Hypertensive heart disease.
Diamond JA; Phillips RA
Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
[TBL] [Abstract][Full Text] [Related]
12. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
Agabiti-Rosei E
Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension and the heart].
Wachtell K; Andersen NH; Svendsen TL
Ugeskr Laeger; 2009 Jun; 171(25):2113-6. PubMed ID: 19671394
[TBL] [Abstract][Full Text] [Related]
14. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
15. [Physiopathology of left ventricular hypertrophy].
Waeber B; Weber R; Brunner HR
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():9-14. PubMed ID: 7646313
[TBL] [Abstract][Full Text] [Related]
16. Prevention and reduction of left ventricular hypertrophy in the elderly.
Lavie CJ; Milani RV; Messerli FH
Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
[TBL] [Abstract][Full Text] [Related]
17. Single-drug therapy and reduction of left ventricular mass in hypertension.
Gottdiener JS
Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy as a risk factor in hypertension.
Balogun MO; Dunn FG
Afr J Med Med Sci; 1996 Sep; 25(3):277-83. PubMed ID: 10457806
[TBL] [Abstract][Full Text] [Related]
19. Prevention, diagnosis, and treatment of hypertensive heart disease.
Georgiopoulou VV; Kalogeropoulos AP; Raggi P; Butler J
Cardiol Clin; 2010 Nov; 28(4):675-91. PubMed ID: 20937450
[TBL] [Abstract][Full Text] [Related]
20. [Regression of left ventricular hypertrophy in hypertensive heart disease].
Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
